The Food and Drug Administration approved Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin from Eli Lilly, for adults with type 2 diabetes, the agency said in an announcement dated September 24, 2026. According to the FDA, it is only the second once-weekly insulin ever approved for type 2 diabetes in the United States — a small but real shift…

Wellness

discover practical tips and motivation to start living a healthier lifestyle. embrace wellness with easy habits, inspiration, and guidance to begin your journey to better health today.

Women's

Diet and Weight Loss

Patient Stories

Senior